GoodRx
GDRX
#3721
Rank
$2.09 B
Marketcap
$5.30
Share price
-0.38%
Change (1 day)
-77.93%
Change (1 year)

P/E ratio for GoodRx (GDRX)

P/E ratio as of January 2023 (TTM): -46.7

According to GoodRx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -46.6795. At the end of 2020 the company had a P/E ratio of -47.2.

P/E ratio history for GoodRx from 2020 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2020-47.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
19.5-141.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.